Breaks Categories: News

ThursdayDec 14, 2017 10:36 am

HempNewsBreaks – Marijuana Company of America, Inc. (MCOA) Adds New Pain Product to Lineup

Marijuana Company of America (OTC: MCOA) announced today the launch of its new personal care product hempSMART Pain for the temporary treatment of minor pain associated with physical activity using non-psychoactive cannabidiol. "HempSMART demonstrated its commitment to formulating a safe and synergistic natural personal care product. The hempSMART Pain formula harnesses the natural power of premium CBD, CBG and active terpenes derived from industrial hemp, combined with complimentary botanicals,” Paula Vetter, a member of hempSMART's product development team, stated in a news release about the product. To view the full press release, visit http://cnw.fm/G61Yr. About Marijuana Company of America, Inc.…

Continue Reading

WednesdayDec 13, 2017 11:43 am

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Granted U.S. Patent Regarding DehydraTECH™ Technology

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) reported this morning that it has been granted a patent from the United States Patent and Trademark Office ("USPTO") increasing its intellectual property (“IP”) hold of its DehydraTECH™ technology. The newly-issued patent covers the use of DehydraTECH™ technology as a delivery platform for a broad range of Active Pharmaceutical Ingredients ("APIs") including all cannabinoids, fat soluble vitamins, non-steroidal anti-inflammatory pain medications ("NSAIDs"), and nicotine. In addition, Lexaria continues to advance all of its other patent applications worldwide. “This ground-breaking, patented IP builds a foundation for new business opportunities in 2018 including what could be…

Continue Reading

WednesdayDec 13, 2017 9:58 am

HempNewsBreaks – PotNetwork Holding, Inc. (POTN) Named One of Five Notable CBD Revolution Industry Leaders

PotNetwork Holding (OTC: POTN) today indicated that it has been recently featured as one in five companies in an article highlighting the bolstering emergence of the Cannabidiol (“CBD”) industry by Huffington Post.  The article detailed the evolution of the U.S. cannabis industry over the past five years, with over 22 states including the District of Columbia authorizing cannabis for medical and recreational use. The North America Cannabis market is projected to be worth $20 billion by 2020. The article highlights PotNetwork’s dedication to the research, development, and multi-national distribution of premium hemp extracts that contain natural hemp derivatives and a…

Continue Reading

WednesdayDec 13, 2017 9:31 am

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Subsidiary Spin Off

ChineseInvestors.com (OTCQB: CIIX) today announced plans to spin off its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., and its wholly-owned subsidiary, ChineseHempOil.com, Inc. in an effort to transition the subsidiary from a private startup to a successful public company. This change will allow the company to focus on its new Cryptocurrency Division and Core Financial Education Business. CIIX will be registered as a separate publically-traded company, and the Consumer Products Division (including its hemp oil assets and new wholesale alcohol division) will operate for both United States and China markets at the end of February 2018. The Company will pursue…

Continue Reading

WednesdayDec 13, 2017 9:13 am

HempNewsBreaks – Global Payout, Inc. (GOHE) Executes LOI with SinglePoint, Inc. (SING)

Payment solutions company Global Payout (OTC: GOHE) this morning said that it has entered a Letter of Intent (“LOI”) with mobile technology provider SinglePoint (OTC: SING). Through this collaboration, Global Payout intends to build on its existing collection of financial technology solutions, including those used by its MoneyTrac Technology, Inc. (“MTRAC”) subsidiary. Additionally, the companies intend to examine potential technology optimization prospects that may be possible through the establishment of a joint venture. “SinglePoint’s knowledge and expertise in mobile payments and other mobile technology offerings is something we believe could be a significant addition to the financial payment platforms we…

Continue Reading

TuesdayDec 12, 2017 10:09 am

HempNewsBreaks – SinglePoint, Inc. (SING) Reports Key 2017 JV Achievements; Eyes Next Year’s Initiatives

SinglePoint (OTC: SING) today announced considerable growth in 2017 and success in key advances of its corporate mission with the launch of additional joint ventures and the closing of new deals within existing agreements. The company also provided a recap of 2017 achievements, as well as outlined key initiatives for 2018. Within the news release, SinglePoint president Wil Ralston stated, “Through strategic joint ventures and inside development of applications, we are pushing hard on providing a compliant solution to the cannabis industry. Our team and others have worked well in collaboration and believe we are not far away from an…

Continue Reading

TuesdayDec 12, 2017 9:55 am

HempNewsBreaks – PotNetwork Holding, Inc. (POTN) Completes Initial Audit Requirement to Up-List

PotNetwork Holding (OTC: POTN) today announced the successful completion of the first segment of its audit requirement for up-listing to the OTCQB, as well as long-term goal of achieving a NASDQ Capital Market listing. As part of the initial review, East West Accounting Services, LLC has satisfied compliance parameters and expects completion of the full audit by the second week of January 2018. Regarding successful completion of the initial phase, PotNetwork Holding CEO Rick Goulding stated in the news release, “We are very pleased that this segment of the process is completed.” To view the full press release, visit http://cnw.fm/B0yAn…

Continue Reading

TuesdayDec 12, 2017 9:29 am

HempNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Inks LOI to Acquire Outstanding Shares of Harvest Medicine Inc.

Abcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning said that the company recently entered into a binding Letter of Intent (“LOI”) dated December 11, 2017 to acquire all outstanding securities of Canada’s fastest growing medical cannabis clinic, Harvest Medicine Inc. Per the terms of the agreement, Abcann will make a $1,500,000 cash payment and issue 1,056,338 common shares in the capital of ABcann valued at $1,500,000, based on a deemed price of $1.42 per share. Upon the closing of the transaction, Harvest Medicine founder and CEO, Shekhar Parmar, is anticipated to join ABcann’s executive team as Chief Strategy Officer and…

Continue Reading

MondayDec 11, 2017 9:33 am

HempNewsBreaks – EVIO, Inc. (EVIO) Signs Non-Binding LOI to Acquire Licensed Cannabis Laboratory in Berkeley, CA

EVIO (OTCQB: EVIO) this morning announced that it has signed a non-binding Letter of Intent (“LOI”) to acquire 60% of C3 Labs, LLC. C3 Labs is located in Berkeley, CA, which accelerates the company’s intent to expand into Northern California prior to the anticipated increase in demand for analytical testing services. Subject to customary closing conditions, the transaction is expected to close in the first quarter of 2018. “C3 Labs been serving the cannabis industry for years, providing product formulation, research and development services that aligns with EVIO’s longer term strategy to expand our scope of services. We are working…

Continue Reading

FridayDec 08, 2017 8:31 am

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Retains Medical Director to Advise Cannabis Research Programs

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning reported that the company has hired Dr. M. Scott Alexander as a medical director. Alexander’s role will be to confirm the medical integrity of cannabis research programs conducted by the company’s subsidiary, Cannevert Therapeutics Ltd. In addition, Alexander will develop a medical affairs strategy to support cannabis strains currently in development. “Dr. Alexander brings a wealth of medical knowledge, a clear understanding of current clinical practice and regulatory needs, and a pledge to educate all stakeholders about therapeutic strains that are based on Cannevert’s experimental evidence,” Veritas CEO Dr. Lui…

Continue Reading